Objective of the present work is to develop and validate a simple, cost effective, sensitive and fast HPLC method for the analysis of Secnidazole. A Merck-Hitachi HPLC system with Peerless Basic C18 (50mm x 4.6mm x 3μm) column is employed for the analysis using buffer: methanol (80:20, v/v) as mobile phase. Signal from Secnidazole is detected at 310nm by UV Spectrophotometer. The proposed method is fully validated and found to be linear over a workable drug concentration, accurate, precise and robust. This fast and inexpensive method is suitable for research laboratories as well as for quality control analysis in pharmaceutical industries.
Apremilast is approved by USFDA in 2014. It is used in treatment of psoriatic arthritis and other conditions like atopic dermatitis and plaque psoriasis. It is act as an anti-inflammatory agent. It is phthalimide derivative and belongs to class 4 category of BCS system. It is a phosphodiesterase-4 (PDE-4) inhibitor. Analytical methods plays an important role to describe physico-chemical properties of drug. Due to low solubility and low permeability analytical method development and formulation becomes challenging. Till date, there are no standard test methods available to analyze Apremilast. So, a review of the analytical methods for apremilast is carried out. Here we discussed latest analytical methods for estimation of apremilast in bulk, Pharmaceuticals dosage form and in biological samples. In that we study methods like HPLC, UV-Visible spectroscopy, HPTLC, UPLC and mostly used hyphenated technique LC-MS. This review will be helpful for the researcher who is working on apremilast.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.